Nanjing IASO Biotherapeutics announced that it has raised funds in a round of funding on January 13, 2023. The transaction included participation from new investors, Shanghai Chuanghehui Investment Management Co., Ltd. and Jointown Pharmaceutical Group Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.35 CNY | +1.71% | +3.34% | +19.12% |
Apr. 29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
Apr. 29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.12% | 4.41B | |
+15.21% | 70.09B | |
-2.19% | 24.01B | |
+8.13% | 8.32B | |
-18.28% | 8.23B | |
+0.73% | 8.08B | |
0.00% | 4.12B | |
-3.02% | 3.88B | |
+23.97% | 3.71B | |
+8.99% | 3.39B |
- Stock Market
- Equities
- 600998 Stock
- News Jointown Pharmaceutical Group Co., Ltd
- Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd